Dabigatran: An Oral Novel Potent Reversible Nonpeptide Inhibitor of Thrombin

Dabigatran Etexilate

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation

Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated With Dabigatran or Warfarin

Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice